Evidence map›Paper›PMID 37580126›Full record

ArticleRNA (New York, N.Y.)2023

Discovering pathways through ribozyme fitness landscapes using information theoretic quantification of epistasis.

Nathaniel Charest, Yuning Shen, Yei-Chen Lai, Irene A Chen, Joan-Emma Shea

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nathaniel CharestDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106, USA.
Yuning ShenDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106, USA.
Yei-Chen LaiDepartment of Chemistry, National Chung Hsing University, Taichung City 40227, Taiwan.
Irene A ChenDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106, USA shea@chem.ucsb.edu ireneachen@ucla.edu.ORCID 0000-0001-6040-7927
Joan-Emma SheaDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106, USA shea@chem.ucsb.edu ireneachen@ucla.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of catalytic RNAs is typically achieved through primarily experimental means. However, only a small fraction of sequence space can be analyzed even with high-throughput techniques. Methods to extrapolate from a limited data set to predict additional ribozyme sequences, particularly in a human-interpretable fashion, could be useful both for designing new functional RNAs and for generating greater understanding about a ribozyme fitness landscape. Using information theory, we express the effects of epistasis (i.e., deviations from additivity) on a ribozyme. This representation was incorporated into a simple model of the epistatic fitness landscape, which identified potentially exploitable combinations of mutations. We used this model to theoretically predict mutants of high activity for a self-aminoacylating ribozyme, identifying potentially active triple and quadruple mutants beyond the experimental data set of single and double mutants. The predictions were validated experimentally, with nine out of nine sequences being accurately predicted to have high activity. This set of sequences included mutants that form a previously unknown evolutionary "bridge" between two ribozyme families that share a common motif. Individual steps in the method could be examined, understood, and guided by a human, combining interpretability and performance in a simple model to predict ribozyme sequences by extrapolation.

Indexed as

RNA, CatalyticBiological EvolutionEpistasis, GeneticGenetic FitnessHumansMutationRNA, Catalyticepistasisfitness landscapemutual informationribozymesurprisal

Identifiers

PMID37580126
PMCPMC10578471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.